Bioengineered artificial skin or bioengineered skin substitutes are medical devices used to treat severe burn injuries and wounds. These skin substitutes provide an environment that promotes the regeneration of new functional skin with reduced complications and scarring. The major products in this market include acellular fish skin grafts, acellular skin allografts,biosynthetic skin grafts, and tissue-engineered skin substitutes. The increasing prevalence of burn injuries and trauma cases globally is fueling the demand for these skin substitutes.

The global bioengineered artificial skin market is estimated to be valued at US$ 3.32 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period of 2023 to 2030.

Key Takeaways

Key players operating in the bioengineered artificial skin are Genoskin, Smith and Nephew Inc., Genzyme Biosurgery, Vericel Corporation, AROA BIOSURGERY LIMITED, Integra LifeSciences Corp, COOK BIOTECH, Mölnlycke Health Care AB, Avita Medical, MiMedx Group, Inc., and Organogenesis Holdings Inc. These players are focusing on new product launches and innovations to consolidate their market position.

The major opportunities in the market include a large patient pool suffering from burns and chronic wounds globally. According to the WHO, around 180,000 people die annually from burns sustained during emergencies like building collapses, fires, and earthquakes. Significant investments in research to develop better tissue-engineered skin substitutes can lead to many commercial opportunities.

The market is witnessing rapid global expansion with companies focusing on expanding their operations in lucrative markets such as Asia Pacific and Middle East & Africa. The presence of high unmet needs and demand from the developing countries provides huge scope for various players in these regions.

Market Drivers

- Growing geriatric population worldwide susceptible to chronic wounds and traumatic injuries

- Increasing prevalence of burn injuries due to various reasons such as fire, explosions, electricity

- Advancements in tissue engineering and manufacturing processes leading to development of better skin substitutes

- Rising medical expenditures and healthcare investments in emerging countries

Market Restraints

- High costs associated with bioengineered skin substitutes limiting widespread adoption

- Limited donor sites and shortage of skin grafts for large surface area burns

- Long development timelines and complex regulatory pathways for new skin substitute products

Segment Analysis

The bioengineered artificial skin market is dominated by the permanent artificial skins segment which accounts for over 50% of the market share. These artificial skins permanently integrate with the skin of patients and helps replace or treat severe burns and other wounds. They mimic the structure and biochemical composition of natural skin and have advanced waterproofing and anti-microbial properties. This makes them very useful for treating extensive burn injuries that cover large portions of the body. The demand for such advanced artificial skins is increasing in developed nations as their development and success rates are high.

The temporary artificial skin and accessories segment is the second largest, dominated by dressings and bandages used temporarily till the patient's own skin grows back or they undergo skin grafting. These find widespread applicability as first aid treatment for minor burns and wounds.

Regional Analysis

North America dominates the global bioengineered artificial skin market with the largest share owing to aggressive research & development activities being undertaken in the space. The market in the US is the major revenue generator, supported by high healthcare expenditure and presence of major artificial skin manufacturers. Europe holds the second position led by Germany, France and the UK. However, Asia Pacific is emerging as the fastest growing regional market with China and India experiencing rapid economic development and healthcare infrastructure expansion. Rising medical tourism and presence of contract research organizations are attracting Western medical device companies towards Asia Pacific.

Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.

(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/